ML-assisted diffuse reflectance spectroscopy: validation-planning checklist

A review-derived conceptual checklist for planning ML-assisted diffuse-reflectance spectroscopy research: rigorous sample stratification, in-vivo validation and explainable algorithm development.

Workflow level n/a Source Preprint (not peer-reviewed) Outcome Not empirically evaluated here

Evidence & verification

Source level

Preprint (not peer-reviewed)
Grounded in a preprint that had not completed peer review at the time the source was checked.

Outcome verification

Not empirically evaluated here
A documented resource or intended workflow, not a demonstrated academic outcome. No empirical benefit is established by its inclusion.

Sources checked

2026-10-17 (UTC)

Primary descriptive evidence is the arXiv abstract. The reported 77-study corpus and broad diagnostic potential are author statements, not independently audited outcomes. The checklist use is an independent AI editorial suggestion.

Source-checked does not mean independently reproduced. See the Method page for how these labels are assigned.

Sources (1)

Research applicability

Helps researchers frame validation questions when designing ML analysis of diffuse-reflectance spectroscopy data, without treating published diagnostic-accuracy claims as established clinical benefit.

Getting started

Editorial, untested: read the abstract and complete review, turn its three priorities into study-specific questions, and consult spectroscopy, statistics and clinical/ethics specialists before planning data collection or in-vivo validation.

Maintenance

Source accessed 2026-10-17; no software maintenance, hosting, compatibility or clinical-deployment assessment.

License

Permissions for the article, any data and any code must be checked separately; no general open-licence or redistribution claim.

Workflow & human oversight

Workflow level intentionally unspecified for a conceptual reference. Researchers choose study designs, obtain appropriate approvals and validate conclusions; no autonomous clinical decision-making is proposed.

Workflow level is not an evidence score; higher is not better evidence.

Approach

The systematic-review abstract identifies three research priorities after reviewing ML-based tissue-differentiation studies. This entry uses those priorities as a bounded editorial planning checklist, not as an implemented classifier, detailed experimental protocol or validated clinical system.

Limitations

Abstract-only review of a 2025 systematic-review preprint. The reported 77-study corpus was not audited. No diagnostic model, detailed stratification protocol, in-vivo performance, clinical efficacy or executable pipeline was inspected or reproduced. The proposed checklist is an editorial, untested use of the authors' stated research priorities.

Reproducibility

No model, code, diagnostic outcome or clinical experiment was executed or reproduced. Source and quote checks are not experimental replication.

Adoption requirements

Editorial, untested use: spectroscopy and ML expertise, lawful data access, an appropriate sample-stratification and validation plan, and ethics/safety review for any human-subject or in-vivo study. Detailed protocols, code and clinical suitability must be assessed separately.

Comments

No comments yet.

Add a comment

Comments are held for moderation before appearing. Critical or corrective comments are welcome — especially evidence that an entry overstates what has been verified.